Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The partcipants on this board do a remarkable job in digging up info.

I gave you a thumbs up.

I will add one thought to yours because you wrote:

"When you consider the low amount of shares held by management and the board members, it is obvious they are not convinced that the "patent or patents on water" are that easy to enforce through the USPTO or the courts."

I would offer that is not necessarily the only way of seeing the viewpoints of the board and management. Precisely because they are board and management they are invested in ways that we as shareholders can not be invested. They have options and bonuses and buyout payoffs that will reward them if the company succeeds. So why would they buy stock when there is risk? The way it is set up now for them they profit with less risk of capital. And they are investing their time as well. One could also they are investing their expertise and risking their reputations, but I won't get into that in this post, LOL.

Could someone tell us how many shares the board is entitled to with all their options and bonuses and any other moneys that would come their way when PTSC succeeds?

Share
New Message
Please login to post a reply